SCHEMBL7990328

SCHEMBL7990328

CC(=O)c1ccc(O)c(OCC(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
PTGDR2 Q9Y5Y4 1/20 0.49
HTT P42858 2/20 0.49
PKM P14618 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
RAB9A P51151 1/20 0.46
APP P05067 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GLA P06280 1/20 0.45
PPARD Q03181 1/20 0.44
CREBBP Q92793 1/20 0.44
SMPD1 P17405 1/20 0.43
HSD17B2 P37059 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637573 0.86 KMT2A (0.60) KMT2AMEN1PTGDR2L3MBTL1POLB
SCHEMBL19335483 0.85 PKM (0.47) KMT2AMEN1HTTPKMSLC22A6
SCHEMBL12111023 0.83 CREBBP (0.63) KMT2AMEN1HTTPKML3MBTL1
SCHEMBL5907838 0.82 KMT2A (0.73) KMT2AMEN1HTTPOLBSMN1; SMN2
SCHEMBL29171621 0.81 CREBBP (0.61) KMT2AMEN1HTTPKML3MBTL1
SCHEMBL3014488 0.80 PTGDR2 (0.53) KMT2AMEN1PTGDR2PPARDCREBBP
SCHEMBL9540583 0.80 MAOB (0.60) KMT2AMEN1HTTRAB9AL3MBTL1
SCHEMBL17037234 0.79 ALDH1A1 (0.58) KMT2AMEN1HTTPKMSLC22A6
SCHEMBL5533467 0.79 FFAR1 (0.52) KMT2AMEN1PTGDR2HTTPKM
SCHEMBL7566116 0.79 PTGDR2 (0.63) KMT2AMEN1PTGDR2PKMCREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291530-B1 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity NOVARTIS AG (CH) 2001-09-18 US disclosed
EP-0942903-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY Novartis AG (CH) 1999-09-22 EP disclosed
WO-1998013347-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY NOVARTIS AG (CH) 1998-04-02 WO disclosed